1. General
  • Education & Academic Titles
    • University of Athens, Medical School, medical degree "very good" 1986

    Training in Internal Medicine

    • Athens Naval Hospital, department of internal medicine.
    • Saint Panteleimon General Hospital of Piraeus, department of internal medicine

    Retraining in Medical Oncology

    • Hammersmith-Royal Postgraduate School of medicine, research in monoclonal antibodies against human malignant tumors
    • St Bartholomew’s Hospital London, ICRF Unit, lymphomas, and bone marrow transplantation
  • Professional Experience
    • 1913-2022: Director of third Oncology Clinic at «Metropolitan" Hospital
    • From 2009 to 2013: Director of Chemotherapy Unit at General Hospital of Athens Ippokrateio
    • From 1990 to 2009Director of second Clinical Oncology department at Cancer Hospital of Athens "Saint Savas"
    • From 1985 to 2000: Consultant, Department of Oncology, Antikarkiniko Hospital Piraeus "Metaxas Memorial"
    • From 1985 to 2000: Internist, Department of Oncology, Antikarkiniko Hospital Piraeus "Metaxas Memorial"
    • Consultant, internal medicine, County General Hospital of Kalamata
  • Clinical Interest
    • Solid tumors, breast, lung, neuroendocrine neoplasms
    • Lung Cancer
  • Awards & Distinctions
    • Praises from the Athens Academy for the unit of bone marrow transplantation ST Sava’s hospital
    • Academy of Athens award for the Unit of phycological support of women with breast cancer of Greek Society of Mastology
  • Recent Publications
    1. Barbounis V., Petounis A., Pectasidis D. and Razis D. Productivity of clinical trials in ovarian cancer. Medical Ethics and/or ethical medicine. Eds G. Mathe, D. Razis, M. Gsrynberg-Jodean. Elsevier, Paris, 1989, p. 114-121.
    2. Barbounis V.P., Kalofonos H.P., Munro A.S., Mc Kenzie C.G., Sackier J.M. and Epenetos A.A. Treatment of Colorectal Cancer and other malignancies with continuous infusion of 5-Fluorouracil. Anticancer Research 1989, 9: 33-40.
    3. Efremidis A. A phase II study of ondansetron as antiemetic prophylaxis in patients receiving high dose polychemotherapy and stem cell transplantation. Support Care Cancer 1995, 3:
    4. Barbounis V. and Efremidis A. Castleman's disease. Anticancer Recearch 1996, 16: 545-548.
    5. Barbounis V., Hajichristou H., Vassilomanolakis M., Koumakis G., Tsoussis S. and Efremidis A. The efficacy of ondansetron against acute emesis and nausea in patients treated with megatherapy and autologous bone marrow rescue. Journal of Chemotherapy suppl (1) 1993, 5: 750-751.
    6. Barbounis V. Progress and Controversies in Hodgkin's disease. Journal of Chemotherapy suppl (1) 1993, 5: 780-781.
    7. Barbounis V., Athanassiou A., Karvounis V., Kosmidis P., Karabelis A., Hatziyanni M. and Seitanides V. A randomized trial comparing the combination of Ceftazidime/Amikacin vs Pefloxacin/Amikacin in cancer patients with fever and neutropenia. Eur.Journal Clin Microbiol Infect Disease, special issue 1991, 601-602.
    8. Ioannidou-Mouzaka L. and Barbounis V. The role of adjuvant treatment in breast cancer with negative axillary nodes. 8th International Meeting of Gynaecological Oncology: Main lectures, debates, special lectures. Eds: Dexens S., Lopez Marin L., Labastida R. Barcelona 1993, p. 132-138.
    9. Pectasides D., Barbounis V., Sintila A., Varthalitis I., Dimitriadis M. and Athanassiou A. Treatment of primary fallopian tube carcinoma with cisplatin containing chemotherapy. Am. J. Clin. Oncol. 1994, 17 (1): 68-71.
    10. Oza A.M., Ganesan T.S., Leahy M., Gregory W., Lim J., Barbounis V. et al. Patterns of survival in patients with Hodgkin's disease. Long follow up in a single centre. Annals of Oncology 1993, 4 (5): 385-392.
    11. Oza A.M., Ganesan T.S., Dorreen M., Johnson P.W., Waxman J., Barbounis V. et al. Patterns of survival in patients with advanced Hodgkin's disease treated in a single centre over 20 years. British Journal of cancer 1992, 65 (3): 429-437.
    12. Pectasides D., Barbounis V., Athanassiou A., Mariatos P. Cerebrovascular accidents following hormonochemotherapy in cancer patients. Am. J. Clin. Oncol. 1992, 15 (2): 168-173.
    13. Athanassiou A., Barbounis V., Dimitriadis M., Pectasidis D., Bafaloukos D. Successful chemotherapy for disseminated testicular sertoli cell tumour. British Journal of Urology 1988, 61 (5) 456-457.
    14. On behalf of Greek Lymphoma Research Group. Preliminary Results with and Alternating Combination in Non-Hodgkin's Malignant Lymphomas. Chemotherapia Suppl. 10 No2 4, 1985, p.
    15. On behalf of Greek Lymphoma Research Group. Treatment of Resistant Non-Hodgkin's Lymphomas with Cisplatin, Etoposide, Vindesine, Methotrexate with Leucovorin Rescue. Chemotherapia Suppl. 10 No 2. Vol. 4, 1985 p.
    16. Karachalios G., Georgiopoulos A., Karamitsos D., Barbounis V. et al. Parenteral amoxycillin therapy in acute Bacterial Pneumonia. Clinical Trials Journal, 1982, 19 (5): 275-278.
    17. Karachalios G., Donas G., Bountas S., Georgiopoulos A., Kottaridi H., Karamitsos D., Kalofonos H. and Barbounis V. Combination trimethoprim - sulphamethoxazole therapy in urinary tract infections. Clinical trials Journal 1982 19 (3): 144-147.
    18. Pectasides D., Alevizakos N., Barbounis V., Athanassiou A. Transient cerebral dysfunction after treatment with moderately high-dose methotrexate. Annals of Oncology 1991, 2 (10) 769.
    19. Pectasides D., Kayianni H., Facon A., Bobotas N., Barbounis V. et al. Correlation of abdominal computed tomography scanning and second look operation findings in ovarian cancer patients. Am. J. Clin. Oncol. 1991, 14 (6): 457-462.
    20. Athanassiou A., Pectasides D., Bafaloukos D., Barbounis V. et al. Treatment of disseminated germ cell tumours of the testis. British Journal of Urology 1989, 63 (5): 525-530.
    21. Pectasides D., Vonorta P., Tsialta - Salihou A., Pateniotis K., Barbounis V. et al. Immunoscintigraphy with 131I labelled H17E2 monoclonal antibody compared with conventional lymphangiography and computed tomography in the detection of metastases in patients with testicular germ cell tumours. British Journal of Cancer Suppl 1990 10: 74-77.
    22. Athanassiou A.E., Bafaloukos D., Pectasides D., Dimitriadis M., Varthalitis I. and Barbounis V. First line combination chemotherapy with cisplatin and etoposide in advanced ovarian cancer. British Journal of Cancer 1989, 60 (5): 755-758.
    23. Pectasides D., Yianniotis H., Alevizakos N., Bafaloukos D., Barbounis V. et at. Treatment of metastatic malignant melanoma with dacarbazine, Vindesine and cisplatin. British Journal of Cancer 1989, 60 (4): 627-629.
    24. Hatzichristou H., Koumakis G., Vassilomanolakis M., Barbounis V., Tsoussis S. and Efremidis A. Hematopoietic growth factors in autologous bone marrow transplantation for solid tumours and lymphomas. Journal of Chemotherapy suppl 1. 1993, 5: 744-745.
    25. V.Barbounis. Neoadjuvant chemotherapy in breast cancer. Proceedings of the IInd National Meeting of the Hellenic Society of Gynaecological Oncology. European Journal of Gynaecological Oncology 1996, 17:414-417.
    26. Efremidis AP, Koumakis G, Filis J, Moraki M, Vassilomanolakis M, Barbounis V, et al. Peripheral blood progenitor cell (PBPC) transplantation with a single apheresis in various malignancies. Bone Marrow Transplantation 1996 17: 673-674.
    27. Koumakis G, Filis J, Vassilomanolakis M, Papanastassiou K, Hatjichristou H, Barbounis V, Stamatellou M, Efremidis A. Relation between hematological recovery and number of transplated mononuclear cells in patients after high dose chemotherapy with periperal blood stem cell rescue. Blood Cells, Molecules and Diseases 1995, 21: 235-238.
    28. Efremidis AP, Koumakis G, Filis J, Vassilomanolakis M, Hatzichristou H, Barbounis V, et al. Peripheral blood progenitor cell (PBPC) transplantation with a signle apheresis in patients with lymphoma myeloma and solid tumors. Eur. J. Haematol 1996, 57; 269-277.
    29. Koumakis G, Vassilomanolakis M, Hatzichristou H, Barbounis V, Filis J, Papanastasiou K, et al. Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single apheresis (SA) for rescuing patients after high dose chemotherapy (H.D.CHE) in various malignancies. Bone Marrow Transplantation 18, 1065-1072, 1996.
    30. M.Vassilomanolakis, G.Koumakis, V.Barbounis, H.Hatjichristou, S.Tsousis, A.Efremidis. A phase II study of flutamide in ovarian cancer. Oncology 1997; 54: 199-202.
    31. V.Barbounis, G.Koumakis, Helen Hatzichristou, M.Vassilomanolakis, S.Tsoussis and Anna Efremidis. The antiemetic efficacy of tropisetron plus Dexamethasone in patients treated with high dose chemotherapy and stem cell transplantation. Supportive Care Cancer 1999.
    32. G.Koumakis, M.Vassilomanolakis, V.Barbounis, H.Hatzichristou, S.Demiri, G.Plataniotis, F.Pamouktsoglou, A.P. Efremidis. Optimal timing (proemptive us supportive) of Granulocyte Colony Stimulating Factor Administration following High - Dose Cyclophosphamide. Oncology 1999; 56:28-35
  • Membership in Societies and Editorial Boards
    • President Greek College of Senology
    • Ex-General secretary Greek society of Mastology
    • Ex-Director of training courses in Mastology
    • Ex-Editor of FORUM OF CLINICAL ONCOLOGY, the Greek Society of Clinical Oncologists magazine
  • Research
    • Editor of ten books in Oncology
    • Author of 14 chapters in oncology books
    • 40 publications in peer review journals
    • 400 lectures at conferences Enlightenment of public about cancer prevention
    • Organizer of numerous oncological conferences
    • Participation in organization of more than 70 conferences or congresses about cancer